07.10.2021 08:38:17

Moderna Announces Investment To Build MRNA Manufacturing Facility In Africa

(RTTNews) - Moderna, Inc. (MRNA) said it will build a state-of-the-art mRNA facility in Africa with the goal of producing up to 500 million doses of vaccines each year at the 50 g dose level. The company plans to invest up to $500 million in this facility.

"We expect to manufacture our COVID-19 vaccine as well as additional products within our mRNA vaccine portfolio at this facility," said Stephane Bancel, Moderna's Chief Executive Officer.

Moderna expects to begin a process for country and site selection soon.

Analysen zu Moderna Incmehr Analysen

19.11.24 Moderna Hold Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
13.09.24 Moderna Underweight JP Morgan Chase & Co.
05.08.24 Moderna Sector Perform RBC Capital Markets
12.01.24 Moderna Outperform RBC Capital Markets
03.11.23 Moderna Buy Goldman Sachs Group Inc.
Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Moderna Inc 41,17 -2,60% Moderna Inc